Example collocations logo

Drugs in sentence

2204 examples of Drugs in a sentence

Their feelings of anger and helplessness, compounded by poor education and soaring unemployment, often drove them toward alcohol and drugs.
It kept the faithful off drugs, and provided employment in its enterprises, offering not only a livelihood, but also a sense of meaning and purpose.
Africa’s private sector, in particular, has a crucial role to play in developing innovative solutions that address malaria’s growing resistance to existing drugs, as well as mosquitoes’ growing resistance to insecticides.
For example, to cope with toxic drugs, a cancer cell may increase its rate of DNA repair, or actively pump the drug out across the cell membrane.
In targeted therapies, in which drugs interfere with the molecular signaling needed for proliferation and survival, a cell might adapt by activating or following alternative pathways.
The Council of Economic Advisers, whose members write the president’s report, surmise that structural changes – including stronger incentives for efficiency by hospitals and providers, more cost-sharing in insurance policies, and the substitution of generic drugs for branded drugs – explain most of the deceleration in per capita spending growth.
Price regulations and other ill-considered features of European policy contribute to the fact that 60% of the world's new drugs are developed in the US, compared to 40% only ten years ago.
With new patent laws coming into place, India will have the same attraction for the pharmaceutical industry as it has for IT, providing clinical trials for new drugs at a quarter of the cost of Europe or the US.
These microdevices would be made of silicon or other materials that can be loaded with drugs (or sensors) and covered with caps made of gold or other substances.
Such systems have the potential to deliver new kinds of drugs in complex regimens which might be useful for cancer chemotherapy, for example.
They could also provide new means of localized drug delivery that might be useful in several areas, including delivery of multiple drugs.
But if scientists can develop better delivery systems or synthetic agents that are safer, cheaper, and easier to manufacture, enormous opportunities will be created for complex drugs that could be given without injections.
New advances in engineering medicine may help in targeting drugs at specific cells, particularly cancer cells, which has been extremely difficult to do for several reasons.
Likewise, movie stars often fall victim to alcohol, drugs, and breakdowns, but at least they have chosen the lives they live.
In Ghana, 15 days’ wages pays for a 30-day supply of just two of the drugs needed to prevent complications.
We must tackle deficiencies in distribution systems that limit access to drugs and diagnostics, driving up costs.
The ability to determine the principal genes that account for our variable response to prescription drugs has been advanced by a technique known as a genome-wide association study (GWAS).
Using GWAS methodology, we have learned the biological basis for responses to many drugs – both their effectiveness and important side-effects.
There are alternative drugs, such as prasugrel or ticagrelor, which can be used instead of Plavix to bypass the problem.
We now know that a simple genotype sorts out who will or will not benefit from interferon, and there are many new drugs in development for those who will not.
Genotyping can also predict severe liver toxicity for drugs such as flucloxacillin or lumiricoxib.
Furthermore, most drugs have not even been studied yet, so there is a long way to go fill in the holes.
Two of the largest PBMs, Medco and CVS/Caremark, have announced plans to conduct large-scale genotyping for many drugs.
Their motives include more efficient use of prescription drugs, along with getting an edge on other PBM competitors.
With annual expenditures for prescription drugs in the US totaling $300 billion, there is certainly room to cut costs.
Unfortunately, the medical community is resisting the use of pharmacogenomic data in clinical practice, despite regulatory authorities’ recommendations for many drugs.
At its core, globalization entails the increasing volume, velocity, and importance of flows – within and across borders – of people, ideas, greenhouse gases, goods, dollars, drugs, viruses, emails, weapons, and a good deal else, challenging one of sovereignty’s fundamental principles: the ability to control what crosses borders in either direction.
Preparedness requires coordination among agencies and funders to build networks that enable quick deployment of and access to vaccines, drugs, and protocols that limit a disease’s transmission.
Breaking the distorting power of these criminal networks requires first confronting the distortions that perpetuate it: the failed war on drugs and criminalization of consumers; the burgeoning privatization of security; police agencies that reproduce, rather than reduce, violence and crime; prisons that hone offenders’ criminal skills; and judicial systems that re-victimize crime victims.
As a result, international cooperation to counter illegal fishing, smuggling of weapons and drugs, human trafficking, piracy, and the use of vessels in terrorist operations has been greatly hampered.
BackNext